Feasiblity and Safety of Home-based Intensive Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Acute Leukemia
Interventions
OTHER

Home-based chemotherapy

To investigate the feasibility and safety of home-based intensive chemotherapy in patients with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). Furthermore, we examined the quality of life (QOL) and psychological wellbeing while receiving induction and consolidation chemotherapy at home.

Trial Locations (6)

2100

Rigshospitalet, Copenhagen

2730

Herlev Hospital, Herlev

4000

Sjællandsuniversitetshospital Roskilde, Roskilde

Unknown

Aalborg University Hospital, Aalborg

Aarhus University Hospital, Aarhus

Odense University Hospital, Odense

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT04904211 - Feasiblity and Safety of Home-based Intensive Chemotherapy | Biotech Hunter | Biotech Hunter